The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Consolidated revenue from operations stood at Rs. 111.05 crore
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Phase 3 program for NDV-01 in non-muscle invasive bladder cancer expected to begin in the first half of 2026
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Subscribe To Our Newsletter & Stay Updated